Indian Journal of Transplantation

INVITED COMMENTARY
Year
: 2021  |  Volume : 15  |  Issue : 1  |  Page : 4--13

Pretransplant histocompatibility testing algorithm: Laboratory and clinical approach in the Indian context


Feroz Aziz1, Aseem K Tiwari2, Himanshu V Patel3, Rajni Chauhan2 
1 Department of Nephrology and Transplantation, IQRAA International Hospital and Research Center, Laboratory of Transplant Immunology, Aster MIMS Hospital, Kozhikode, Kerala, India
2 Department of Transfusion Medicine, Molecular and Transplant Immunology Laboratory, Medanta - The Medicity Hospital, Gurugram, Haryana, India
3 Department of Nephrology and Transplantation, Institute of Kidney Diseases and Research Center, Dr. H L Trivedi Institute of Transplantation Sciences, Ahmedabad, Gujarat, India

Correspondence Address:
Dr. Feroz Aziz
Department of Nephrology and Transplantation, Laboratory of Transplant Immunology, Aster MIMS Hospital, IQRAA International Hospital and Research Center, Kozhikode - 673 016, Kerala
India

Remarkable advances in histocompatibility testing have immensely improved the safety of transplantation and have decreased the incidence of rejections. Human leukocyte antigen (HLA) typing and crossmatches by complement-dependent cytotoxicity or flow cytometer-based methods are the vital tests involved in pretransplant histocompatibility testing. Continuous development in these testing technologies since the 1960s has refined these methodologies that can be used to predict graft rejection. Advancements from polymerase chain reaction-based methods to sequence based in HLA typing, and from cell-based cross-matches to virtual cross-matches using advanced solid-phase platforms, have enhanced our understanding about the donor-specific antibodies (DSAs) and have challenged the concept that the presence of DSA is an absolute contraindication to transplantation. Despite various developments, it is very difficult to perform a plethora of tests for pretransplant workup due to cost constraints in a developing country like India. In this review, we would discuss the advantages, limitations, and cost involved in the pretransplant immunologic workup along with an algorithmic approach for physicians that may help in decision-making amidst multiple information from different platforms.


How to cite this article:
Aziz F, Tiwari AK, Patel HV, Chauhan R. Pretransplant histocompatibility testing algorithm: Laboratory and clinical approach in the Indian context.Indian J Transplant 2021;15:4-13


How to cite this URL:
Aziz F, Tiwari AK, Patel HV, Chauhan R. Pretransplant histocompatibility testing algorithm: Laboratory and clinical approach in the Indian context. Indian J Transplant [serial online] 2021 [cited 2021 Apr 11 ];15:4-13
Available from: https://www.ijtonline.in/article.asp?issn=2212-0017;year=2021;volume=15;issue=1;spage=4;epage=13;aulast=Aziz;type=0